Provided by Tiger Trade Technology Pte. Ltd.

Tonix Pharmaceuticals

12.83
-0.3300-2.51%
Pre-market: 12.890.0600+0.47%08:14 EDT
Volume:167.53K
Turnover:2.16M
Market Cap:220.05M
PE:-1.03
High:13.12
Open:13.09
Low:12.80
Close:13.16
52wk High:31.55
52wk Low:9.40
Shares:17.15M
Float Shares:14.99M
Volume Ratio:0.47
T/O Rate:1.12%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-12.4882
EPS(LYR):-14.5713
ROE:-81.82%
ROA:-46.84%
PB:0.99
PE(LYR):-0.88

Loading ...

Tonix Plans Adaptive Phase 2 Trial of TNX-4800 Antibody to Prevent Lyme Disease, Targets Q1 2027 Start

Reuters
·
Aug 03

Tonix Pharmaceuticals - Plans to Start Phase 2 Tnx-4800 Study in Q1 2027

THOMSON REUTERS
·
Aug 03

Tonix Pharmaceuticals Announces Positive Minutes from Type C FDA Meeting to Discuss Adaptive Phase 2 Field Study of Tnx-4800, a Human, Anti-Ospa Monoclonal Antibody, to Prevent Lyme Disease in the U.S.

THOMSON REUTERS
·
Aug 03

Tonix Pharmaceuticals - Majority of Enrollment Expected in 2028 Season, May Extend into 2029

THOMSON REUTERS
·
Aug 03

Tonix Pharmaceuticals Posts Investor Deck Focused on Tonmya Fibromyalgia Launch and Pipeline Updates

Reuters
·
Jul 28

Tonix Pharma to Report Q2 Results, Host Conference Call and Webcast

Reuters
·
Jul 27

Tonix Pharma CMO Gregory Sullivan to Retire Aug. 20

Reuters
·
Jul 22

Tonix Pharmaceuticals Publishes Investor Deck Highlighting Tonmya Fibromyalgia Launch Strategy

Reuters
·
Jul 20

Tonix Pharmaceuticals Investor Deck Spotlights Tonmya Fibromyalgia Launch and Late-stage Pipeline Plans

Reuters
·
Jul 17

Tonix Publishes Journal of Virology Study Showing 2022 Mpox Clade Iib up to 100,000-fold Less Virulent than 2003 Clade Iia

Reuters
·
Jul 15

Tonix Pharmaceuticals Announces Publication in the Peer-Reviewed Journal of Virology Assessing Virulence of the 2022 Outbreak Strain of Mpox in New Animal Models

GlobeNewswire
·
Jul 15

Wall Street Analysts Are Bullish on Top Healthcare Picks

TIPRANKS
·
Jul 13

Tonix Rises on Medicare Coverage Expansion for Chronic Pain Treatment

Reuters
·
Jul 13

Tonix Pharmaceuticals Announces Major Managed Medicare Payer Agreement for Tonmya®

THOMSON REUTERS
·
Jul 13

Tonix Pharmaceuticals - Announces Medicare Agreement for Tonmya Adding 9 Mln Lives Effective Jan 1, 2027

THOMSON REUTERS
·
Jul 13

Tonix Pharmaceuticals Posts Investor Deck Spotlighting Tonmya Fibromyalgia Launch Strategy

Reuters
·
Jul 08

Analysts’ Top Healthcare Picks: Tonix Pharma (TNXP), Carlsmed, Inc. (CARL)

TIPRANKS
·
Jul 01

Tonix Pharmaceuticals - Enrolls First Patient in Phase 2 Horizon Study of Tnx-102 Sl for Mdd - SEC Filing

THOMSON REUTERS
·
Jun 29

Tonix Pharmaceuticals - Primary Endpoint is Change in Madrs Total Score at Week 6 - SEC Filing

THOMSON REUTERS
·
Jun 29

Tonix Enrolls First Patient in Phase 2 Trial of Tnx-102 SL for Major Depressive Disorder

Reuters
·
Jun 29